Remove tag eye-tracking
article thumbnail

bluebird bio wins back-to-back landmark FDA approvals for first-in-class gene therapies

Pharmaceutical Technology

Spark Therapeutics’ Luxturna, indicated for inherited retinal disease (IRD), was the first gene therapy to be approved, in 2017, with a price tag of $850,000 for each eye. Prior to bluebird's approvals, there were only two FDA-approved gene therapies for inherited conditions on the market.

article thumbnail

Anti-Counterfeiting Technologies in Healthcare

Roots Analysis

Anti-counterfeiting technologies technologies can be broadly classified under two categories, namely Authentication Technologies and Track & Trace Technologies. Most of them are visible to the naked eye. Track & Trace technologies constitute a separate segment in the anti-counterfeiting technologies market.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

7 Social Media Tactics to Increase Webinar Registrations

XTalks

Additionally, keep track of which hashtags are performing well for each platform so you can focus on the most effective ones. For example, create an eye-catching image that ties in with the topic of the webinar and post it on your timeline. You can also create a short video that explains the benefits of attending your webinar.

article thumbnail

Patient adherence – the key to restoring trust in pharma

pharmaphorum

What people did not understand was that “fast tracking” approval does not limit the rigorous process involved in ensuring that a medication or vaccine is safe for market use. Given the high price tags placed on many medications, it’s easy to understand why patients often feel that they are being taken advantage of.

article thumbnail

Roche’s quantitative COVID-19 antibody test; Janssen buys a gene therapy asset; Zimmer Acquires A&E Medical; Glaucoma research study: Merck chooses TriNKET cancer immunotherapy program; Ovid fails Angelman phase 3 study

Delveinsight

The company anticipates the test can aid in tracking the success of vaccines and recognize people who have recovered from infection and could serve as convalescent plasma donors or help in the development of new therapies. Janssen buys a new gene therapy aimed at reversing a severe disease, from Hemera Biosciences.

article thumbnail

Women in Science Who Have Paved the Way Forward in Genetics

XTalks

Through the radioactive labels, they were able to track which of the two, DNA or protein, was injected into the bacteria. They conducted two experiments, one with radioactive phosphorous to label DNA, and one with radioactive sulfur to tag protein (DNA does not contain sulfur and protein does not contain phosphate groups).

Genetics 119
article thumbnail

Merck KGaA raises full-year forecast; Perlmutter’s new gig tackles ‘undruggable targets’

The Pharma Data

Pharma showers Menendez with rare, off-cycle burst of campaign cash as Democrats eye drug pricing reforms ( STAT ). CureVac says well on track to request vaccine approval as planned ( Reuters ) ( NYT ). Lilly hit by staff accusations, FDA scrutiny at COVID drug factories ( Reuters ).